Brandon Luber

29.8k citations

40 papers · 4.5k indexed · 5 hit papers · h-index 24

Impact in

Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Cancer Research top 1%
- Cancer Genomics and Diagnostics

Papers in

Oncology 25
- Cancer Immunotherapy and Biomarkers 12
- PARP inhibition in cancer therapy 3
Pulmonary and Respiratory Medicine 20
- Prostate Cancer Treatment and Research 16

Co-authors: Hao WangBert Vogelstein Emmanuel S. Antonarakis Robert A. Anders Drew M. Pardoll Nickolas Papadopoulos Kenneth W. Kinzler Franck Housseau
Journals: Journal of Clinical Oncology (11 papers)Cancer Research (3 papers)The Prostate (3 papers)Cancer Immunology Research (3 papers)Journal of Nuclear Medicine (2 papers)
Partner nations: United States South Korea Japan

In The Last Decade

Brandon Luber

40 papers receiving 4.5k citations

Hit Papers

5 papers align trajectories log scale

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide 2017 · 340 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Journal of Clinical Oncology
2016 Science
2015 Journal of Clinical Oncology
2015 JAMA Oncology
2014 Cancer Discovery

Peers

Countries citing papers authored by Brandon Luber

Since Specialization

Citations

This map shows the geographic impact of Brandon Luber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Luber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Luber more than expected).

Fields of papers citing papers by Brandon Luber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Luber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Luber. The network helps show where Brandon Luber may publish in the future.

Co-authors

The 25 scholars most cited alongside Brandon Luber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brandon Luber Line = papers co-authored together Brandon Luber links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma Scientific Reports ·Swetha Kambhampati Thiruvengadam, Alan H. Tieu, Brandon Luber, Hao Wang, Stephen J. Meltzer	2020	46
2	Immunopathologic Stratification of Colorectal Cancer for Checkpoint Blockade Immunotherapy Cancer Immunology Research ·Nicolás J. Llosa, Brandon Luber, Nicholas Siegel, Anas H. Awan, Teniola Oke, Qingfeng Zhu, Bjarne R. Bartlett, Laveet K. Aulakh, Elizabeth D. Thompson, Elizabeth M. Jaffee, Jennifer N. Durham, Cynthia L. Sears, Dung T. Le, Luis A. Díaz, Drew M. Pardoll, Hao Wang, Franck Housseau, Robert A. Anders	2019	32
3	Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide European Urology ·Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, Chao Liang, Hao Wang, Yan Chen, John L. Silberstein, Danilo Piana, Zhao Lai, Yidong Chen, William B. Isaacs, Jun Luo	2018	132
4	Quantitation of Cancer Treatment Response by ¹⁸F-FDG PET/CT: Multicenter Assessment of Measurement Variability Journal of Nuclear Medicine ·Joo Hyun O, Heather A. Jacene, Brandon Luber, Hao Wang, Minh-Huy Huynh, Jeffrey P. Leal, Richard L. Wahl	2017	12
5	Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study The Lancet Oncology ·Benjamin A. Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind, Ashley Bruns, Avery Spitz, Morgan Decarli, Victoria J. Sinibaldi, Caroline F. Pratz, Changxue Lu, John L. Silberstein, Jun Luo, Michael T. Schweizer, Charles G. Drake, Michael A. Carducci, Channing J. Paller, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade	2017	137
6	Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients Biology of Blood and Marrow Transplantation ·Nicolás J. Llosa, Kenneth R. Cooke, Allen Chen, Christopher Gamper, Orly R. Klein, Elias T. Zambidis, Brandon Luber, Gary L. Rosner, Nicholas Siegel, Mary Jo Holuba, Nancy Robey, Masanori Hayashi, Richard J. Jones, Ephraim J. Fuchs, Matthias Holdhoff, David M. Loeb, Heather J. Symons	2017	17
7	Phase 2 biomarker-driven study of ipilimumab plus nivolumab (Ipi/Nivo) for ARV7-positive metastatic castrate-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Karim Boudadi, Daniel L. Suzman, Brandon Luber, Hao Wang, John L. Silberstein, Rana Sullivan, Donna Dowling, Rana Harb, Thomas R. Nirschl, Ryan Dittamore, Michael A. Carducci, Mario A. Eisenberger, Michael C. Haffner, Alan K. Meeker, James R. Eshleman, Jun Luo, Charles G. Drake, Emmanuel S. Antonarakis	2017	24
8	Risk Factors for Progression of Barrett's Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma: A Large Retrospective Cohort Study Gastroenterology ·Swetha Kambhampati Thiruvengadam, Brandon Luber, Hao Wang, Stephen J. Meltzer	2017	1
9	Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer Cancer Chemotherapy and Pharmacology ·Benjamin L. Maughan, Daniel L. Suzman, Brandon Luber, Hao Wang, Stephanie Glavaris, Robert M. Hughes, Rana Sullivan, Rana Harb, Karim Boudadi, Channing J. Paller, Mario A. Eisenberger, Angelo M. De Marzo, Ashely Ross, Emmanuel S. Antonarakis	2016	21
10	Response to Early Treatment Evaluated with ¹⁸F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor Journal of Nuclear Medicine ·Joo Hyun O, Brandon Luber, Jeffrey P. Leal, Hao Wang, Vanessa Bolejack, Scott M. Schuetze, Lawrence H. Schwartz, Lee J. Helman, Denise K. Reinke, Laurence H. Baker, Richard L. Wahl	2016	18
11	Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria CardioVascular and Interventional Radiology ·Andrew J. Gunn, Rahul A. Sheth, Brandon Luber, M. Huynh, Niranjan Rachamreddy, Sanjeeva P. Kalva	2016	4
12	Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells Science ·Kaitlyn Sadtler, Kenneth Estrellas, Brian W. Allen, Matthew T. Wolf, Hongni Fan, Ada Tam, Chirag H. Patel, Brandon Luber, Hao Wang, Kathryn R. Wagner, Jonathan D. Powell, Franck Housseau, Drew M. Pardoll, Jennifer H. Elisseeff Hit paper breakdown →	2016	470
13	Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience Annals of Surgical Oncology ·Jingya Wang, Amol Narang, Elizabeth A. Sugar, Brandon Luber, Lauren M. Rosati, Charles C. Hsu, Clifton D. Fuller, Timothy M. Pawlik, Robert C. Miller, Brian G. Czito, Richard Tuli, Christopher H. Crane, Edgar Ben‐Josef, Charles R. Thomas, Joseph M. Herman	2015	27
14	Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting Journal of Translational Medicine ·Evan J. Lipson, William H. Sharfman, Shuming Chen, Tracee L. McMiller, Theresa S. Pritchard, January T. Salas, Susan Sartorius‐Mergenthaler, Irwin Freed, Sowmya Ravi, Hao Wang, Brandon Luber, Janice Davis Sproul, Janis M. Taube, Drew M. Pardoll, Suzanne L. Topalian	2015	73
15	PD-1 blockade in tumors with mismatch repair deficiency. Journal of Clinical Oncology ·Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra Eyring, Andrew D. Skora, Nilofer S. Azad, Daniel A. Laheru, Ross C. Donehower, Brandon Luber, Todd S. Crocenzi, George A. Fisher, Steve M Duffy, James J. Lee, Minori Koshiji, James R. Eshleman, Robert A. Anders, Bert Vogelstein, Luis A. Díaz Hit paper breakdown →	2015	339
16	The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints Cancer Discovery ·Nicolás J. Llosa, Michael Cruise, Ada Tam, Elizabeth C. Wicks, Elizabeth M. Hechenbleikner, Janis M. Taube, Richard L. Blosser, Hongni Fan, Hao Wang, Brandon Luber, Ming Zhang, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Cynthia L. Sears, Robert A. Anders, Drew M. Pardoll, Franck Housseau Hit paper breakdown →	2014	1112
17	PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation Cancer Immunology Research ·Nemanja Rodić, Robert A. Anders, James R. Eshleman, Ming-Tseh Lin, Haiying Xu, Jung Ho Kim, Katie Beierl, Shuming Chen, Brandon Luber, Hao Wang, Suzanne L. Topalian, Drew M. Pardoll, Janis M. Taube	2014	42
18	Clinical activity of enzalutamide versus docetaxel in men with castration‐resistant prostate cancer progressing after abiraterone The Prostate ·Daniel L. Suzman, Brandon Luber, Michael T. Schweizer, Rosa Nadal, Emmanuel S. Antonarakis	2014	79
19	Ar-V7 Splice Variant and Resistance to Enzalutamide and Abiraterone in Men with Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Overall Survival Results Annals of Oncology ·Emmanuel S. Antonarakis, Changxue Lu, Hui Wang, Brandon Luber, Mari Nakazawa, Jeffrey C. Roeser, Y. Chen, Helen Fedor, Tamara L. Lotan, Qizhi Zheng, Angelo M. De Marzo, John T. Isaacs, William B. Isaacs, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Jun Luo	2014	2
20	Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology ·Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mari Nakazawa, Yan Chen, Jeffrey C. Roeser, Helen Fedor, Tamara L. Lotan, Qizhi Zheng, Angelo M. De Marzo, John T. Isaacs, William B. Isaacs, Rosa Nadal, Channing J. Paller, Samuel R. Denmeade, Michael A. Carducci, Mario A. Eisenberger, Jun Luo	2014	17

About Brandon Luber

Brandon Luber is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Pathology and Forensic Medicine, having authored 40 papers that have together received 4.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Genetic factors in colorectal cancer (9 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Genomics and Diagnostics (4 papers), Hormonal and reproductive studies (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations), Pulmonary and Respiratory Medicine (1.8k citations), Pathology and Forensic Medicine (774 citations) and Immunology (764 citations). Brandon Luber has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Hao Wang, Bert Vogelstein, Emmanuel S. Antonarakis, Robert A. Anders, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Franck Housseau, Ada Tam and Hongni Fan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, The Prostate, Cancer Immunology Research and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact